You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 3, March 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  BRIEF COMMUNICATIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Lafora's Disease

Comparison of Inclusion Bodies in Skin and in Brain

Bert L. S. M. Busard, MD; Willy O. Renier, MD; Fons J. M. Gabreëls, MD; Henk H. J. Jaspar, MD; Urbaan J. G. van Haelst, MD; Joop L. Slooff, MD

Arch Neurol. 1986;43(3):296-299.


Abstract

• A patient had the clinical and neuropathologic signs of Lafora's disease. Skin biopsy specimens from the midcalf area confirmed earlier findings by showing numerous periodic acid-Schiff-positive inclusion bodies in eccrine sweat gland duct cells. In our patient, however, inclusion bodies were more abundantly present in the apocrine sweat gland duct cells of the axilla skin. In brain biopsy specimens and autopsy material the same periodic acid-Schiff-positive inclusion bodies were found. From these data it can be stated that skin biopsy of the axilla is the method of first choice in confirming the diagnosis.



Author Affiliations

From the Institutes of Neurology (Drs Busard, Renier, Gabreëls, and Jaspar) and Pathology (Drs van Haelst and Slooff), Radboud University Hospital, Nijmegen, the Netherlands.


Footnotes

Accepted for publication June 20, 1985.

Reprint requests to Institute of Neurology, Division of Child Neurology, Radboud University Hospital, Box 9101,6500 HB Nijmegen, the Netherlands (Dr Gabreëls).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype
Ganesh et al.
Hum Mol Genet 2002;11:1263-1271.
ABSTRACT | FULL TEXT  

A Unique Carbohydrate Binding Domain Targets the Lafora Disease Phosphatase to Glycogen
Wang et al.
J. Biol. Chem. 2002;277:2377-2380.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.